Glimepiride 3 mg
- Product NDC
- 72336-641
- 11-digit product format
- 723360641
- Labeler code
- 72336
- Product ID
- 72336-641_8f56950f-d08d-44d4-9c7c-9830e9bfadb8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glimepiride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lifsa Drugs LLC
- Application
- ANDA091220
- Marketing category
- ANDA
- Marketing start
- 2024-08-20
- Substance
- GLIMEPIRIDE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glimepiride 3 mg
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIMEPIRIDE | 3 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6KY687524K |
| Rxcui | 153842 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72336-641-01 | Glimepiride 3 mg | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72336-641 | GLIMEPIRIDE 3 MG (GLIMEPIRIDE) TABLET [LIFSA DRUGS LLC] | 1 | Current NDC, 1 package rows | 20240824_51157849-7990-4a8b-ae50-eda1baf93cfa.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72336-641-01 | 72336064101 | 100 TABLET in 1 BOTTLE (72336-641-01) | 100 tablet | 2024-08-20 | No | No | Current |